HHLR ADVISORS LTD. 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:39 pm Sale | 2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB | HHLR ADVISORS LTD. | 6,657,030 4.900% | -2,027,500 (-23.35%) | Filing |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Cytek Biosciences, Inc. CTKB | HHLR ADVISORS LTD. | 8,684,530 6.400% | -72,500 (-0.83%) | Filing |
| 2022-02-14 4:09 pm Purchase | 2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB | HHLR ADVISORS LTD. | 8,757,030 6.500% | 8,757,030 (New Position) | Filing |